Isabel Brand, Leonard Gilberg, Jan Bruger, Mercè Garí, Andreas Wieser, Tabea M Eser, Jonathan Frese, Mohamed I M Ahmed, Raquel Rubio-Acero, Jessica M Guggenbuehl Noller, Noemi Castelletti, Jana Diekmannshemke, Sophie Thiesbrummel, Duc Huynh, Simon Winter, Inge Kroidl, Christiane Fuchs, Michael Hoelscher, Julia Roider, Sebastian Kobold, Michael Pritsch, Christof Geldmacher
Frontiers in immunology 2021Adaptive immune responses to structural proteins of the virion play a crucial role in protection against coronavirus disease 2019 (COVID-19). We therefore studied T cell responses against multiple SARS-CoV-2 structural proteins in a large cohort using a simple, fast, and high-throughput approach. An automated interferon gamma release assay (IGRA) for the Nucleocapsid (NC)-, Membrane (M)-, Spike-C-terminus (SCT)-, and N-terminus-protein (SNT)-specific T cell responses was performed using fresh whole blood from study subjects with convalescent, confirmed COVID-19 (n = 177, more than 200 days post infection), exposed household members (n = 145), and unexposed controls (n = 85). SARS-CoV-2-specific antibodies were assessed using Elecsys® Anti-SARS-CoV-2 (Ro-N-Ig) and Anti-SARS-CoV-2-ELISA (IgG) (EI-S1-IgG). 156 of 177 (88%) previously PCR confirmed cases were still positive by Ro-N-Ig more than 200 days after infection. In T cells, most frequently the M-protein was targeted by 88% seropositive, PCR confirmed cases, followed by SCT (85%), NC (82%), and SNT (73%), whereas each of these antigens was recognized by less than 14% of non-exposed control subjects. Broad targeting of these structural virion proteins was characteristic of convalescent SARS-CoV-2 infection; 68% of all seropositive individuals targeted all four tested antigens. Indeed, anti-NC antibody titer correlated loosely, but significantly with the magnitude and breadth of the SARS-CoV-2-specific T cell response. Age, sex, and body mass index were comparable between the different groups. SARS-CoV-2 seropositivity correlates with broad T cell reactivity of the structural virus proteins at 200 days after infection and beyond. The SARS-CoV-2-IGRA can facilitate large scale determination of SARS-CoV-2-specific T cell responses with high accuracy against multiple targets. Copyright © 2021 Brand, Gilberg, Bruger, Garí, Wieser, Eser, Frese, Ahmed, Rubio-Acero, Guggenbuehl Noller, Castelletti, Diekmannshemke, Thiesbrummel, Huynh, Winter, Kroidl, Fuchs, Hoelscher, Roider, Kobold, Pritsch and Geldmacher.
Isabel Brand, Leonard Gilberg, Jan Bruger, Mercè Garí, Andreas Wieser, Tabea M Eser, Jonathan Frese, Mohamed I M Ahmed, Raquel Rubio-Acero, Jessica M Guggenbuehl Noller, Noemi Castelletti, Jana Diekmannshemke, Sophie Thiesbrummel, Duc Huynh, Simon Winter, Inge Kroidl, Christiane Fuchs, Michael Hoelscher, Julia Roider, Sebastian Kobold, Michael Pritsch, Christof Geldmacher. Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay. Frontiers in immunology. 2021;12:688436
PMID: 34093595
View Full Text